BIOMAT Database Logo BIOMAT Database Logo

Neuropsychological status of asymptomatic individuals seropositive to HIV-1. 1989

D H Harter
Howard Hughes Medical Institute, Bethesda, MD.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D H Harter
Neuropsychological function in physically asymptomatic, HIV-seropositive men.
January 1989, The Journal of neuropsychiatry and clinical neurosciences,
D H Harter
Neuropsychological abnormalities in asymptomatic HIV seropositive military personnel.
January 1991, The Journal of neuropsychiatry and clinical neurosciences,
D H Harter
Metacognition in HIV-1 seropositive asymptomatic individuals: self-ratings versus objective neuropsychological performance. Multicenter AIDS Cohort Study (MACS).
September 1991, Journal of clinical and experimental neuropsychology,
D H Harter
Neuropsychological abnormalities in AIDS and asymptomatic HIV seropositive patients.
August 1993, Journal of neurology, neurosurgery, and psychiatry,
D H Harter
Depressed mood and its relationship to neuropsychological test performance in HIV-1 seropositive individuals.
March 1992, Journal of clinical and experimental neuropsychology,
D H Harter
Neuropsychological and neurological function of human immunodeficiency virus seropositive asymptomatic individuals.
February 1989, Archives of neurology,
D H Harter
Do asymptomatic HIV-seropositive individuals show cognitive deficit?
November 1995, AIDS (London, England),
D H Harter
Hydroxyurea toxicity combined with didanosine (ddl) in HIV-1-seropositive asymptomatic individuals.
October 1999, International journal of clinical pharmacology and therapeutics,
D H Harter
Neuropsychological deficits in tests of executive function in asymptomatic and symptomatic HIV-1 seropositive men.
November 1995, Psychological medicine,
D H Harter
Chemokine production in HIV-seropositive long-term asymptomatic individuals.
October 1996, AIDS (London, England),
Copied contents to your clipboard!